Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1980 1
1981 1
1983 2
1984 1
1985 1
1987 1
1988 1
1989 1
1990 1
1992 1
1993 2
1995 2
1997 2
1998 1
1999 1
2002 1
2003 3
2005 4
2006 2
2007 1
2008 3
2009 3
2010 5
2011 5
2012 4
2013 8
2014 11
2015 7
2016 7
2017 11
2018 1
2019 6
2020 19
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

122 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for john j rate
Search for john j ratey instead (2 results)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. SPRINT Research Group, et al. N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9. N Engl J Med. 2015. PMID: 26551272 Free PMC article. Clinical Trial.
The intervention was stopped early after a median follow-up of 3.26 years owing to a significantly lower rate of the primary composite outcome in the intensive-treatment group than in the standard-treatment group (1.65% per year vs. 2.19% per year; hazard ratio with intens …
The intervention was stopped early after a median follow-up of 3.26 years owing to a significantly lower rate of the primary composit …
Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants.
Kirpalani H, Bell EF, Hintz SR, Tan S, Schmidt B, Chaudhary AS, Johnson KJ, Crawford MM, Newman JE, Vohr BR, Carlo WA, D'Angio CT, Kennedy KA, Ohls RK, Poindexter BB, Schibler K, Whyte RK, Widness JA, Zupancic JAF, Wyckoff MH, Truog WE, Walsh MC, Chock VY, Laptook AR, Sokol GM, Yoder BA, Patel RM, Cotten CM, Carmen MF, Devaskar U, Chawla S, Seabrook R, Higgins RD, Das A; Eunice Kennedy Shriver NICHD Neonatal Research Network. Kirpalani H, et al. N Engl J Med. 2020 Dec 31;383(27):2639-2651. doi: 10.1056/NEJMoa2020248. N Engl J Med. 2020. PMID: 33382931 Clinical Trial.
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.
Glasbey JC, Nepogodiev D, Simoes JFF, Omar O, Li E, Venn ML, Pgdme, Abou Chaar MK, Capizzi V, Chaudhry D, Desai A, Edwards JG, Evans JP, Fiore M, Videria JF, Ford SJ, Ganly I, Griffiths EA, Gujjuri RR, Kolias AG, Kaafarani HMA, Minaya-Bravo A, McKay SC, Mohan HM, Roberts KJ, San Miguel-Méndez C, Pockney P, Shaw R, Smart NJ, Stewart GD, Sundar Mrcog S, Vidya R, Bhangu AA; COVIDSurg Collaborative. Glasbey JC, et al. J Clin Oncol. 2021 Jan 1;39(1):66-78. doi: 10.1200/JCO.20.01933. Epub 2020 Oct 6. J Clin Oncol. 2021. PMID: 33021869
This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COV …
This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matche …
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, Hanabusa H, Gupta N, Kulkarni R, Fogarty P, Perry D, Shapiro A, Pasi KJ, Apte S, Nestorov I, Jiang H, Li S, Neelakantan S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Dodd N, Nugent K, Vigliani G, Luk A, Brennan A, Pierce GF; A-LONG Investigators. Mahlangu J, et al. Blood. 2014 Jan 16;123(3):317-25. doi: 10.1182/blood-2013-10-529974. Epub 2013 Nov 13. Blood. 2014. PMID: 24227821 Free PMC article. Clinical Trial.
A subgroup compared recombinant FVIII (rFVIII) and rFVIIIFc pharmacokinetics. End points included annualized bleeding rate (ABR), inhibitor development, and adverse events. The terminal half-life of rFVIIIFc (19.0 hours) was extended 1.5-fold vs rFVIII (12.4 hours; P < …
A subgroup compared recombinant FVIII (rFVIII) and rFVIIIFc pharmacokinetics. End points included annualized bleeding rate (ABR), inh …
Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes.
Harmon HM, Jensen EA, Tan S, Chaudhary AS, Slaughter JL, Bell EF, Wyckoff MH, Hensman AM, Sokol GM, DeMauro SB; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Harmon HM, et al. J Perinatol. 2020 Apr;40(4):616-627. doi: 10.1038/s41372-020-0594-4. Epub 2020 Feb 4. J Perinatol. 2020. PMID: 32020038 Free PMC article.
RESULTS: Compared with infants in the reference group (22-28 DOL-lowest rate), aOR for severe BPD was similar for children given PNS between DOL 8 and 49 but higher among infants treated at DOL 50-63 (aOR 1.77, 95% CI 1.03-3.06), and at DOL 64 (aOR 3.06, 95% CI 1.44-6.48). …
RESULTS: Compared with infants in the reference group (22-28 DOL-lowest rate), aOR for severe BPD was similar for children given PNS …
Effects of extended-release niacin with laropiprant in high-risk patients.
HPS2-THRIVE Collaborative Group, Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, Wallendszus K, Craig M, Jiang L, Collins R, Armitage J. HPS2-THRIVE Collaborative Group, et al. N Engl J Med. 2014 Jul 17;371(3):203-12. doi: 10.1056/NEJMoa1300955. N Engl J Med. 2014. PMID: 25014686 Free article. Clinical Trial.
Assignment to niacin-laropiprant, as compared with assignment to placebo, had no significant effect on the incidence of major vascular events (13.2% and 13.7% of participants with an event, respectively; rate ratio, 0.96; 95% confidence interval [CI], 0.90 to 1.03; P=0.29) …
Assignment to niacin-laropiprant, as compared with assignment to placebo, had no significant effect on the incidence of major vascular event …
Differential discounting in the economic evaluation of healthcare programs.
John J, Koerber F, Schad M. John J, et al. Cost Eff Resour Alloc. 2019 Dec 17;17:29. doi: 10.1186/s12962-019-0196-1. eCollection 2019. Cost Eff Resour Alloc. 2019. PMID: 31866768 Free PMC article.
Assuming a constant elasticity of substitution (CES) utility function, the growth rate of the consumption value of health depends on three variables: the growth rate of consumption, the growth rate of health, and the income elasticity of the willingness to pa …
Assuming a constant elasticity of substitution (CES) utility function, the growth rate of the consumption value of health depends on …
Voluntary perioperative colorectal cancer registry from Kerala-An initial overview.
Krishnan P, Kurumboor P, Varma D, Mallick S, Vayoth SO, Gopalakrishnan U, Hariharan R, Subramaniaiyer M, Aikot S, Nambiar R, Sahadevan S, Rajan R, Natesh B, Sadasivan SR, Bhaskaran V, Usman ST, Leela AM, Sadashiva S, John J, Kamalesh NP, Abraham B, Swaminathan PM, Philip S, Subash R, Sreekumar VI. Krishnan P, et al. Among authors: john j. Indian J Gastroenterol. 2020 Jun;39(3):243-252. doi: 10.1007/s12664-019-00998-9. Epub 2020 Sep 16. Indian J Gastroenterol. 2020. PMID: 32936377
Among them, preoperative bowel preparation was given to 37.68%, minimally invasive surgery (MIS) was performed in 73%, covering stoma in 47% and had an overall leak rate of 3.58%. In colonic malignancies, MIS was performed in 56.74%, covering stoma created in 13% and had a …
Among them, preoperative bowel preparation was given to 37.68%, minimally invasive surgery (MIS) was performed in 73%, covering stoma in 47% …
Bio-Decolorization of Synthetic Dyes by a Halophilic Bacterium Salinivibrio sp.
John J, Dineshram R, Hemalatha KR, Dhassiah MP, Gopal D, Kumar A. John J, et al. Front Microbiol. 2020 Dec 21;11:594011. doi: 10.3389/fmicb.2020.594011. eCollection 2020. Front Microbiol. 2020. PMID: 33414770 Free PMC article.
Within 48 h, more than 80% of decolorization was observed in all tested concentrations of CBB G-250 and Congo red dyes. The rate of decolorization was the highest for Congo red followed by CBB G-250 and then Safranin. ...
Within 48 h, more than 80% of decolorization was observed in all tested concentrations of CBB G-250 and Congo red dyes. The rate of d …
122 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page